TNF and inflammatory bowel disease: These results suggest the efficacy of the booster effect of the third vaccination in PIBD patients regardless of their IBD treatment, and the present findings can be essential evidence to recommend the booster vaccination aggressively, especially for PIBD patients on anti-TNFα.